RxDoctor Payments Data

Bindu Umapathi

Colon & Rectal Surgery · Chevy Chase, MDNPI 1790009413

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.8% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $695 and has fallen 90.5% since, to $66 in 2025.

$2,587in general payments, 2019–2025

Across 68 payments — averaging $38.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$460
  • Intuitive Surgical$392
  • Takeda Pharmaceuticals U.S.A., Inc.$285
  • Medrobotics Inc.$178
  • Boston Scientific$150
  • Janssen Scientific Affairs, LLC$149
  • plus $973 from 17 others

What the payments were for

  • Food & beverage$2,45495%
  • Education$622%
  • Gifts$723%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,587 in reported general payments places this provider in the 60th percentile of 29 colon & rectal surgery providers in Maryland.

See all colon & rectal surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$149,387
Medicare patients
244
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocortisone44$797
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip35$774
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates13$720
Procto-Med HcHydrocortisone19$533
Lidocaine-PrilocaineLidocaine/Prilocaine18$413
Cephalexin18$102
Neomycin Sulfate29$98
Metronidazole32$86
Oxycodone Hcl19$85
Tramadol Hcl11$24

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Chevy Chase

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →